{"sourcedb":"DevicePMAs@therightstef","sourceid":"P060033_S063","text":"Approval for a modification to the regulatory elution specification.  The device, as modified, will be marketed under the trade name medtronic endeavor zotarolimus-eluting coronary stent system and is indicated for improving luminal diameter.","project":"consensus_PMA_Age_Indications"}